Exploring the drug-induced anemia signals in children using electronic medical records

References

• WHO (World Health Organization). (2018). [cited 2019 Feb 15]. Available from: https://www.who.int/
   Google Scholar
• Linnik YA, Tsui EW, Martin IW, et al. The first reported case of concurrent trimethoprim-sulfamethoxazole–induced immune hemolytic anemia and thrombocytopenia. Transfusion. 2017;57(12):2937–2941.
   PubMed Web of Science ®Google Scholar
• Hesdorffer CS, Longo DL. Drug-induced megaloblastic anemia. N Engl J Med. 2015;373(17):1649–1658.
   PubMed Web of Science ®Google Scholar
• David M, Mintzer SN. Billet and Lauren Chmielewski. Drug-induced hematologic syndromes. Adv Hematol. 2009;2009:495863.
   PubMedGoogle Scholar
• Laporte JR, Vidal X, Ballarín E, et al. Possible association between ocular chloramphenicol and aplastic anaemia–the absolute risk is very low. Br J Clin Pharmacol. 1998;46(2):181–184.
   PubMed Web of Science ®Google Scholar
• Uba Nwose E. Prevalence of anemia and risk of adverse bleeding effect of drugs: implication for therapy. Anemia. 2012;2012:795439.
   PubMedGoogle Scholar
• Shander A, Javidroozi M, Ashton ME. Drug-induced anemia and other red cell disorders: a guide in the age of polypharmacy. Curr Clin Pharmacol. 2011;6(4):295.
   PubMedGoogle Scholar
• Ferranti J, Horvath MM, Cozart H, et al. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment. Pediatrics. 2008;121(5):e1201–7.
   PubMed Web of Science ®Google Scholar
• Kadoyama K, Kuwahara A, Yamamori M, et al. Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS. J Exp Clin Cancer Res. 2011;30:93.
   PubMed Web of Science ®Google Scholar
• Hazell L, Shakir SAW. Under-reporting of adverse drug reactions. Drug Saf. 2006;29(5):385–396.
   PubMed Web of Science ®Google Scholar
• Platt R MD, M.Sc, Wilson M, Chan KA, et al. The new sentinel network — improving the evidence of medical-product safety. N Engl J Med. 2009;361(7):645–647.
   PubMed Web of Science ®Google Scholar
• Honigman B, Lee J, Rothschild J, et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc. 2001;8(3):254–266.
   PubMed Web of Science ®Google Scholar
• Wang G, Jung K, Winnenburg R, et al. A method for systematic discovery of adverse drug events from clinical notes. J Am Med Inform Assoc. 2015;22(6):1196.
   PubMed Web of Science ®Google Scholar
• Ramirez E, AJ C, AM B, et al. A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients. Clin Pharmacol Ther. 2009;87(1):74–86.
   PubMed Web of Science ®Google Scholar
• Wang X, Hripcsak G, Markatou M, et al. Active computerized pharmacovigilance using natural language processing, statistics, and electronic health records: a feasibility study. J Am Med Inform Assoc. 2009;16(3):328–337.
   PubMed Web of Science ®Google Scholar
• Baker RD, Greer FR. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics. 2010;126(5):1040–1050.
   PubMed Web of Science ®Google Scholar
• Hauben M, Aronson JK. Defining ‘Signal’ and its subtypes in pharmacovigilance based on a systematic review of previous definitions. Drug Saf. 2009;32(2):99–110.
   PubMed Web of Science ®Google Scholar
• Hill QA, Stamps R, Massey E, et al. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol. 2017;177(2):208–220.
   PubMed Web of Science ®Google Scholar
• Kantarcıoğlu B, Türköz HK, Yılmaz G, et al. Aplastic anemia associated with oral terbinafine: a case report and review of the literatureOral Terbinafin İlişkili Aplastik Anemi: Bir Olgu Sunumu ve Literatür Derlemesi. Turk J Haematol. 2014;31(4):411–416.
   PubMed Web of Science ®Google Scholar
• Calado RT, AB G, Falcao RP. Decreased activity of the multidrug resistance P-glycoprotein in acquired aplastic anaemia: possible pathophysiologic implications. Br J Haematol. 1998;102(5):1157–1161.
   PubMed Web of Science ®Google Scholar
• Calado RT, Garcia AB, Gallo DA, et al. Reduced function of the multidrug resistance P-glycoprotein in CD34+ cells of patients with aplastic anaemia. Br J Haematol. 2002;118(1):320–326.
   PubMed Web of Science ®Google Scholar
• Liu W, Yu D. Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis. Pediatr Allergy Immunol. 2013;25(1):101–102.
   PubMed Web of Science ®Google Scholar
• Arndt PA. Drug-induced immune hemolytic anemia: the last 30 years of changes. Immunohematology. 2014;30(2):44–54.
   PubMedGoogle Scholar
• Arndt PA, Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol. 2005;42(3):137–144.
   PubMed Web of Science ®Google Scholar
• Filippone EJ, WK K, Farber JL. The nephrotoxicity of vancomycin. Clin Pharmacol Ther. 2017;102(3):459–469.
   PubMed Web of Science ®Google Scholar
• Gniadek TJ, Arndt PA, Leger RM, et al. Drug-induced immune hemolytic anemia associated with anti-vancomycin complicated by a paraben antibody. Transfusion. 2018;58(1):181–188.
   PubMed Web of Science ®Google Scholar
• Lai C, Chen C, Lu Y, et al. Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms. Infect Drug Resist. 2018;11:1441–1445.
   PubMed Web of Science ®Google Scholar
• Katukuri GR, Maddala RNM, Ramamoorthi K, et al. Cefoperazone induced gastrointestinal bleeding. J Clin Diagn Res. 2016;10(8):10–11.
   Web of Science ®Google Scholar
• de Martino M, Chiarugi A, Boner A, et al. Working towards an appropriate use of ibuprofen in children: an evidence-based appraisal. Drugs. 2017;77(12):1295–1311.
   PubMed Web of Science ®Google Scholar
• Gryfe CI. Letter: agranulocytosis and aplastic anemia possibly due to ibuprofen. Can Med Assoc J. 1976;114(10):877.
   PubMed Web of Science ®Google Scholar
• Barbaryan A, Iyinagoro C, Nwankwo N, et al. Ibuprofen-induced hemolytic anemia. Case Rep Hematol. 2013;2013:142865.
   PubMedGoogle Scholar
• Chan TK, Todd D, Tso SC. Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency. Br Med J. 1976;2(6046):1227–1229.
   PubMedGoogle Scholar
• Yuill GM. Megaloblastic anaemia due to trimethoprim-sulphamethoxazole therapy in uraemia. Postgrad Med J. 1973;49(568):100–102.
   PubMed Web of Science ®Google Scholar
• Kobrinsky NL, Ramsay NK. Acute megaloblastic anemia induced by high-dose trimethoprim-sulfamethoxazole. Ann Intern Med. 1981;94(6):780.
   PubMed Web of Science ®Google Scholar
• Taha AS, McCloskey C, McSkimming P, et al. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2018;3(7):469–476.
   PubMed Web of Science ®Google Scholar
• Heggarty H. Aspirin and anaemia in childhood. Br Med J. 1974;1(5906):491–492.
   PubMedGoogle Scholar
• Gaskell H, Derry S, Moore RA. Is there an association between low dose aspirin and anemia (without overt bleeding)? Narrative review. BMC Geriatr. 2010;10:71.
   PubMed Web of Science ®Google Scholar
• Kuo HC, Lo MH, Hsieh KS, et al. High-dose aspirin is associated with anemia and does not confer benefit to disease outcomes in kawasaki disease. PloS One. 2015;10(12):e0144603.
   PubMed Web of Science ®Google Scholar
• Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol. 2014;164(4):469–480.
   PubMed Web of Science ®Google Scholar
• Bartsocas CS, Schulman JD and Corash L. Can acetaminophen cause hemolysis in G6PD deficiency? Acta Haematol. 1982;67(3):228.
   PubMed Web of Science ®Google Scholar